Triprolidine
- Level
- Commodity
- Parent
- 51313400
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313410This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2L8T9S52QM. European Medicines Agency schedules Triprolidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11323MIG. Triprolidine generally arises in the molecular formula C19H22N2. The term TRIPROLIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, no. 12, 1959, list 3.) TRIPROLIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule triprolidine under HS 29333999 and SITC 51574. As of Q4 2014, TRIPROLIDINE remains the US FDA Preferred Term for this commodity. Triprolidine bears US NLM identifiers UMLS ID C0041098 and NCI Concept Code C61992. SMILES: N1(CCCC1)C/C=C(/C1CCC(CC1)C)C1NCCCC1.
Same parent
Under 51313400 · 41Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.